TrialJournal of acquired immune deficiency syndromes (1999)2016

Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study.

Anton Pozniak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.